Today, the Institute for Clinical and Economic Review (ICER) published its Final Evidence Report on Lykos Therapeutics’ MDMA-assisted therapy for PTSD.There’s no substantive change from its draft evidence report’s determination, or from the vote of its independent panel which resoundingly rejected the intervention.That is, ICER finds the current evidence inadequate to demonstrate a net health…

Source

Previous articleBuilding a Unified Psychedelic Future: Ethics, Standards, and a Path to Affordable Access
Next articleUnderstanding Microdosing: Integrating Small Doses for Big Therapeutic Gains